PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx™ Addressing Patients with Recurrent Pericarditis
19. Dezember 2024 08:30 ET
|
PRISM MarketView
PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx™
Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index
13. November 2024 08:00 ET
|
PRISM MarketView
Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index
PRISM MarketView Joins ThinkEquity Conference as Official Media Sponsor
21. Oktober 2024 12:23 ET
|
PRISM MarketView
PRISM MarketView Joins ThinkEquity Conference as Official Media Sponsor
PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology
13. September 2024 08:30 ET
|
PRISM MarketView
PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology
Aclarion Added to PRISM Emerging Medical Devices Index
06. September 2024 11:27 ET
|
PRISM MarketView
Aclarion Added to PRISM Emerging Medical Devices Index
PRISM MarketView Features Oncocyte CFO Andrea S. James on Her Career and Leadership in Molecular Diagnostics Technology
20. August 2024 09:00 ET
|
PRISM MarketView
PRISM MarketView Features Oncocyte CFO Andrea S. James on Her Career and Leadership in Molecular Diagnostics Technology
PRISM MarketView Launches AI Infrastructure and Datacenter Index
01. August 2024 08:00 ET
|
PRISM MarketView
PRISM MarketView Launches AI Infrastructure and Datacenter Index
PRISM MarketView Examines Airline Industry Policies, Financial Reports and Consumer Trends
30. Juli 2024 11:15 ET
|
PRISM MarketView
PRISM MarketView Examines Airline Industry Policies, Financial Reports and Consumer Trends
PRISM MarketView Features Q&A with Dr. Ellen Kim: Soligenix's HyBryte™— Lighting the Way Towards Commercial Success with Promising FLASH Study Results
15. Juli 2024 10:16 ET
|
PRISM MarketView
PRISM MarketView Features Q&A with Dr. Ellen Kim: Soligenix's HyBryte™— Lighting the Way Towards Commercial Success with Promising FLASH Study Results
UPDATE -- PRISM MarketView Showcases BioStem Technologies: Impressive Revenue Growth and Strategic Expansion
17. Juni 2024 14:07 ET
|
PRISM MarketView
PRISM MarketView Showcases BioStem Technologies: Impressive Revenue Growth and Strategic Expansion